Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release stays in one workspace.
RCEL
$15.65
-6.34%
RCEL
· AVITA Medical, Inc.
$15.65
-1.06 (-6.34%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's liquidity position and the Company's current forecast of operating results and cash flows, management determined there is substantial doubt about the Company's ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements due to the Company's debt repayment obligations, recurring losses, and historical negative cash flows.”View the 10-Q filed Aug 6, 2026
Market Cap
$484.01M
Shares
30.93M
Volume · Oct 30
597.05K
Avg daily vol (3M)
484.46K
All webcasts
Earnings call · FY2020 Q4
AVITA Medical, Inc. (RCEL) Q4 2020 Earnings Call
Revenue
$3.88M
Diluted EPS
-$0.60
Gross margin
77.5%
Net income
-$12.91M
Research coverage
1 live source
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 12, 2021 · complete as-filed document